Prof. Dr. Sally Elfishawi MD,phD serves as an **Associate Professor of Clinical Pathology** at Cairo University's National Cancer Institute (NCI). Former vice president of the Arabian society for histocompatibility and immunegenemoics (ARSHI)and currently secretary for ARSHI.She also serves as a technical assessor for Immunegenemoics for the Egyptian council for accreditation for ISO15189 standards.
Her Key Achievement include Improving Bone Marrow Transplant Outcomes
Dr. Elfishawi's defining professional achievement lies in her advanced research into **immunogenetics and HLA (tissue compatibility) typing**.
Operating out of the NCI’s Bone Marrow Transplantation Lab Unit, her extensive mapping of genetic markers—specifically how Human Leukocyte Antigen (HLA) systems and Killer Cell Immunoglobulin-like Receptor (KIR) genotypes interact—has directly improved the accuracy of donor matching.
Her main Areas of Focus are
* **Leukemia Biomarkers:** Investigating specific gene mutations and molecular markers to catch blood cancers early and predict how well a patient will respond to treatment.
* **Global Genetic Mapping:** Contributing critical Egyptian population data to international initiatives like the International HLA and Immunogenetics Workshop (IHIW) to ensure global transplantation databases are diverse and accurate.
